Acta Dermato-Venereologica 99-7CompleteContent | Page 28
SHORT COMMUNICATION
705
Increased Risk of Cardiovascular Diseases in Female Rosacea Patients: A Nested Case-control Study
Suvi-Päivikki SINIKUMPU 1,2 , Jari JOKELAINEN 3 , Juha AUVINEN 3,4 , Katri PUUKKA 5,6 , Kari KAIKKONEN 7 , Kaisa TASANEN 1,2 *
and Laura HUILAJA 1,2
1
PEDEGO Research Unit, University of Oulu, 2 Department of Dermatology and Medical Research Center Oulu, Oulu University Hospital P.O.
Box 20, FIN-90029 Oulu, 3 Center for Life Course Health Research, Faculty of Medicine, University of Oulu and Oulu University Hospital, Oulu,
4
Oulunkaari Health Center, Ii, 5 NordLab Oulu, Medical Research Center Oulu, Oulu University Hospital, 6 Department of Clinical Chemistry,
University of Oulu, and 7 Deparment of Cardiology, Medical Research Center Oulu, University and University Hospital of Oulu, Oulu, Finland.
*E-mail: [email protected]
Accepted Mar 8, 2019; E-published Mar 8, 2019
Rosacea is a chronic inflammatory disease with a preva-
lence varying between 1 and 20% and is the highest in
fair-skinned Europeans (1). The appearance of rosacea
differs between the sexes; there is a female predominance
and the onset of the disease is earlier in females than in
males (1). Of the 4 subtypes of rosacea (erythematote-
leangiectatic, papulopustular, ocular and phymatotic)
the erythematoteleangiectatic type is more common in
females and the phymatous type in males (2).
There is a rising consensus that rosacea is not only
limited to the skin but is a chronic systemic inflammatory
disease. Several systemic diseases have recently been
shown to be associated with rosacea (3). However, it is
disputed whether rosacea is associated with cardiovascu-
lar (CV) diseases. The risk for comorbidities in rosacea
has also been suggested to differ between sexes. Egeberg
et al. found that rosacea is associated with type 1 diabetes,
celiac disease, multiple sclerosis and rheumatoid arthritis
particularly in females (4).
The aim of this study was to clarify the CV risk factors
in rosacea patients by comprehensively studying the CV
risk profile of middle-aged patients with rosacea.
PATIENTS AND METHODS
This was a nested case-control study of the Northern Finland
Birth Cohort 1966 (NFBC1966). NFBC1966 is a longitudinal
research program, which initially included 12,058 children, in the
two northernmost provinces in Finland, whose expected dates of
birth were between 1 st of January and 31 st of December 1966. The
whole cohort population has been regularly evaluated, since birth,
by the means of health questionnaires and clinical examinations.
At the age of 46 years the cohort subjects were invited to parti-
cipate in a multidisciplinary health study, which included a full
dermatological examination. A dermatologist or an experienced
resident performed the examination. All skin diseases, including
rosacea, were documented (5).
Evaluable data were available for 1,932 cohort members in the
Oulu area; 292 of which had been diagnosed with rosacea. The
majority of them presented with erythematoteleangiectatic rosa-
cea (n = 242, 82.9%), while 45 cases (15.4%) had papulopustular
rosacea. Three cases (1.0%) had symptoms of phymatous rosacea
and one case (0.3%) had ocular rosacea. Each case was matched to
two control subjects by body mass index (BMI) and tobacco use.
Controls were free from both rosacea and other skin diseases and
presented only with benign melanocytic naevi. (Table SI 1 ) Cardio-
https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-3167
1
vascular risk factors were comprehensively studied in all subjects
and the carotid intima-media thickness (CIMT) was assessed by a
cardiologist. All methods are described in detail in Appendix S1 1 .
The characteristics of the study population are presented as
proportions, means and medians. The Mann-Whitney U-test and
Person’s Chi-square test were used to compare the distribution of
cardiovascular risk factors in rosacea cases and controls. Statis-
tical analyses were performed using the SAS software package
(version 9.4, SAS Institute, Inc, Cary, NC) and a p-value < 0.05
was considered statistically significant.
Confounders
Socioeconomic status (SES) was based on the education level,
which has been defined as the most specific indicator of the
socioeconomic status. The cohort members were classified into
3 subgroups based on education. Data concerning education
were obtained from the National Education Register and were
supplemented by self-reported questionnaires, regarding perso-
nal educational history. Study participants were classified into 4
groups according to the body mass index (BMI) (Table SI 1 ). The
information on smoking, physical activity, alcohol consumption
and skin type was self-reported (5).
RESULTS
We found that the mean CIMT was significantly greater
in the rosacea group than in controls, as were levels of
insulin and serum free testosterone. The free androgen
index was significantly higher in female rosacea patients.
Other cardiovascular risk factors did not differ between
the female groups (Table SII 1 ). None of the studied risk
factors were associated with rosacea in male patients
(data not shown).
DISCUSSION
We found that females with rosacea had increased CIMT
when compared with the controls. CIMT has been con-
sidered as a surrogate marker of atherosclerosis and an
early stage of hidden systemic inflammation (6). An in-
creased CIMT is associated with several CV risk factors
and with prevalent CV diseases, such as stroke (6). Our
finding supports the previous finding of Belli et al. who
first reported the relationship between rosacea and CIMT
(7). However, the association has not been previously
studied by sexes. Our female study cases with rosacea
had increased testosterone and insulin levels. High testos-
terone levels correlate with the degree of atherosclerosis
This is an open access article under the CC BY-NC license. www.medicaljournals.se/acta
Journal Compilation © 2019 Acta Dermato-Venereologica.
doi: 10.2340/00015555-3167
Acta Derm Venereol 2019; 99: 705–706